» Articles » PMID: 24285922

Allergenicity and Toxicology of Inhaled Silver Nanoparticles in Allergen-provocation Mice Models

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2013 Nov 29
PMID 24285922
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Silver nanoparticles (AgNP) have been associated with the exacerbation of airway hyperresponsiveness. However, the allergenicity and toxicology of AgNP in healthy and allergic individuals are unclear. We investigated the pathophysiological responses to AgNP inhalation in a murine model of asthma. Continuous and stable levels of 33 nm AgNP were maintained at 3.3 mg/m(3) during the experimental period. AgNP exposure concomitant with ovalbumin challenge increased the enhanced pause (Penh) in the control and allergic groups. AgNP evoked neutrophil, lymphocyte and eosinophil infiltration into the airways and elevated the levels of allergic markers (immunoglobulin E [IgE] and leukotriene E4 [LTE4]), the type 2 T helper (Th2) cytokine interleukin-13 (IL-13), and oxidative stress (8-hydroxy-2'-deoxyguanosine [8-OHdG]) in healthy and allergic mice. Bronchocentric interstitial inflammation was observed after AgNP inhalation. After inhalation, the AgNP accumulated predominantly in the lungs, and trivial amounts of AgNP were excreted in the urine and feces. Furthermore, the AgNP induced inflammatory responses in the peritoneum. The inhalation of AgNP may present safety concerns in healthy and susceptible individuals.

Citing Articles

Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.

Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T Clin Rev Allergy Immunol. 2025; 68(1):12.

PMID: 39928241 PMC: 11811441. DOI: 10.1007/s12016-024-09019-w.


Toxicity and Mechanisms of Engineered Nanoparticles in Animals with Established Allergic Asthma.

Deng R, Zhu Y, Wu X, Wang M Int J Nanomedicine. 2023; 18:3489-3508.

PMID: 37404851 PMC: 10317527. DOI: 10.2147/IJN.S411804.


Mechanistic insights into silica nanoparticle-allergen interactions on antigen presenting cell function in the context of allergic reactions.

Johnson L, Aglas L, Punz B, Dang H, Christ C, Pointner L Nanoscale. 2023; 15(5):2262-2275.

PMID: 36630186 PMC: 9893438. DOI: 10.1039/d2nr05181h.


Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations.

Hofer S, Hofstatter N, Punz B, Hasenkopf I, Johnson L, Himly M Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(6):e1804.

PMID: 36416020 PMC: 9787548. DOI: 10.1002/wnan.1804.


Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.

Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J J Nanobiotechnology. 2022; 20(1):395.

PMID: 36045386 PMC: 9428887. DOI: 10.1186/s12951-022-01605-4.


References
1.
Mei N, Zhang Y, Chen Y, Guo X, Ding W, Ali S . Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ Mol Mutagen. 2012; 53(6):409-19. PMC: 6349369. DOI: 10.1002/em.21698. View

2.
Landsiedel R, Ma-Hock L, Haussmann H, van Ravenzwaay B, Kayser M, Wiench K . Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012; 4(4):399-413. DOI: 10.1002/wnan.1173. View

3.
Cho W, Duffin R, Howie S, Scotton C, Wallace W, MacNee W . Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 2011; 8:27. PMC: 3179432. DOI: 10.1186/1743-8977-8-27. View

4.
Liu H, Yang D, Yang H, Zhang H, Zhang W, Fang Y . Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: silver, zinc oxide and titanium dioxide. J Hazard Mater. 2013; 248-249:478-86. DOI: 10.1016/j.jhazmat.2013.01.046. View

5.
Hao M, Comier S, Wang M, Lee J, Nel A . Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models. J Allergy Clin Immunol. 2003; 112(5):905-14. DOI: 10.1016/j.jaci.2003.07.005. View